Citi raised the firm’s price target on Emerson (EMR) to $127 from $119 and keeps a Buy rating on the shares. The company’s fiscal Q2 orders were ahead of its prior expectations and still healthy underlying project activity, coupled with signs of accelerating order momentum, provide solid visibility for accelerating organic growth over the course of the year, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EMR:
- Emerson price target raised to $104 from $99 at Barclays
- Strong Financial Performance and Strategic Decisions Drive Buy Rating for Emerson Electric
- Emerson Electric Reports Strong Q2 2025 Results
- Emerson Electric Reports Strong Q2, Positive Outlook
- Morning Movers: Disney jumps after first quarter earnings, Abu Dhabi resort plan